Advertisement

The Pattern of Induction of Apoptosis During Infection with MHV-3 Correlates with Strain Variation in Resistance and Susceptibility to Lethal Hepatitis

  • Michail Belyavskyi
  • Gary A. Levy
  • Julian L. Leibowitz
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 440)

Abstract

In the present study we have investigated the possibility that strain specific differences in the induction of apoptosis in macrophages could play a role in the resistance of strain A/J mice to MHV-3 induced hepatitis. MHV-3 infected macrophages from Balb/c and A/J mice were analyzed at various time points after infection. Apoptosis in A/J macrophages could be detected at 8 h post infection and increased significantly by 12 h, when almost 50–70% of the infected cells were undergoing apoptosis. In Balb/c macrophages, apoptotic changes were less pronounced and were observed in only 5–10% of the cells. MHV-3 induced apoptosis was inversely correlated with the ability of this virus to induce expression of fgl-2 prothrombinase protein and syncytia formation. Infected macrophages from A/J mice did not express fgl-2 protein and did not form syncytia. In contrast, infection of Balb/c derived macrophages resulted in fgl-2 expression and extensive syncytia formation. These data fit a model in which apoptosis of virally infected cells is a protective response which eliminates cells whose survival might be harmful for the whole organism.

Keywords

Infected Macrophage Syncytium Formation Mouse Hepatitis Virus Murine Hepatitis Virus Becton Dickinson FACS 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Belyavskyi, M., Miller, J., and Wilson, V., 1994, The bovine papillomavirus El protein alters the host cell cycle and growth properties, Virology 204:132–143.PubMedCrossRefGoogle Scholar
  2. Cuff, S., and Ruby, J., 1996, Evasion of apoptosis by DNA viruses, Immun.Cell Biol. 74: 527–537.CrossRefGoogle Scholar
  3. Dindzans, V., MacPhee, P., Fung, L., Leibowitz, J., and Levy, G., 1985, The immune response to mouse hepatitis virus: expression of monocyte procoagulant activity and plasminogen activator during infection in vivo, J. Immunol. 135:4189–4197.PubMedGoogle Scholar
  4. Dindzans, V., Skamene, E., and Levy, G., 1986, Susceptibility/resistance to mouse hepatitis virus strain 3 and macrophage procoagulant activity are genetically linked and controlled by two non-H2-linked genes, J. Immunol. 137:2355–2360.PubMedGoogle Scholar
  5. Levy, G. A., J. L. Leibowitz, and T. S. Edgington., 1981, The induction of monocyte procoagulant activity by murine hepatitis virus MHV-3 parallels disease susceptibility in mice, J. Exp. Med. 154:1150–1163.PubMedCrossRefGoogle Scholar
  6. Levy, G., MacPhee, P., Fung, L., Fisher, M., and Rappaport, A., 1983, The effect of mouse hepatitis virus infection on microcirculation of the liver, Hepatology 3: 964–973.PubMedCrossRefGoogle Scholar
  7. Macnaughton, M., and Patterson, S., 1980, Mouse hepatitis virus strain 3 infection of C57, A/Sn and A/J strain mice and their macrophages, Arch. Virol. 66:71–75.PubMedCrossRefGoogle Scholar
  8. Parr, R. L., Fung, L. S., Reneker, S. J., Myers-Mason, N., Leibowitz, J. L., and Levy, G. A., 1995, Association of mouse fibrinogen like protein (musfiblp) with murine hepatitis virus induced prothrombinase activity, J. Virol. 69:5033–5038.PubMedGoogle Scholar
  9. Piazza, M., 1969, “Experimental viral hepatitis”. CA Thomas, Springfield, IL.Google Scholar
  10. Schutte, B., Reynders, M., van Assche, C. L. M., Hupperets, P. S. G. J., Bosman, F. T., and Blijham, G. H., 1987, An improved method for the immunocytochemical detection of bromodeoxyuridine labeled nuclei using flow cytometry, Cytometry 8:372–376.PubMedCrossRefGoogle Scholar
  11. Wyllie, A. H., Kerr, J. F. R., and Currie, A. R., 1980, Cell death: The significance of apoptosis, Int. Rev. Cytology 68:251–306.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Michail Belyavskyi
    • 1
  • Gary A. Levy
    • 2
  • Julian L. Leibowitz
    • 1
  1. 1.Department of Pathology and Laboratory MedicineTexas A&M University College of MedicineCollege StationUSA
  2. 2.Multi Organ Transplant ProgramThe Toronto Hospital—University of TorontoTorontoCanada

Personalised recommendations